18th Conference on Retroviruses and Opportunistic Infections (CROI), 27 February-3 March, Boston
This annual conference remains the most important large scientific HIV meeting and is notable for making web casts of oral presentations and lectures rapidly available. Abstracts are online in a searchable database, many of which also include the option to download the PDF poster.
We have plenty to report in this and subsequent issues of HTB, leading with the broad number of papers focusing on new drugs and biomedical interventions to reduce the risk of transmission.
Reports in this issue include:
- Immune-based treatment increases HIV-resistant CD4 cells in phase 1 study
- Antiretroviral prevention: oral PrEP, gels and treatment studies
- Further efficacy analyses from the iPrEx study
- Topical gels as PEP and PrEP: animal and human studies
- Maternal risk following short course HAART
- Pre-term delivery and HAART
- HAART more effective than AZT monotherapy in the Botswana PMTCT programme
- Lopinavir/r monotherapy for PMTCT
- No evidence of increased risk of MTCT with sequential pregnancies in UK and Ireland
- Recently infected women at the time of delivery have a higher rate of in-utero transmission in PEPI-Malawi
- Reduced CCL22 concentrations in cervicovaginal secretions from pregnant women
- When to start ART in patients co-infected with TB: results from two trials presented at CROI